CULVER CITY, Calif. - eTradeWire -- Culver City, CA — May 8, 2026 — Independent inventor Primarch Michael A. Russell today announced Constitutional Mathematics for Antibiotic Discovery, a machine-verifiable implementation framework designed to reframe antibiotic target identification as a structured axiomatic process rather than a purely stochastic search.

The manuscript presents a seven-layer architecture spanning molecular target selection, resistance evolution, pharmacology, clinical validation, economic structure, formal verification, and regulatory pathway design. Within that framework, the paper identifies F0F1 ATP synthase subunit C as the central fixed-point target of the model and proposes a broader method for translating complex biomedical and regulatory problems into machine-checkable constitutional structures.

More on eTradeWire News

• NVUS - Fashion-Focused Social Platform
• High Point Girl Scout Troop Helps Transform Community Garden at Senior Living Community
• Tina Bernard Named ATHENA Leadership Award
• Habitat Broward ReStore Celebrates 25 Years of Community Impact
• TREND Network Announces Official Launch and Exclusive Miami Soft Launch Event

Beyond the biological application, the release emphasizes a domain-agnostic methodology for building verifiable implementations across regulated fields. The work also addresses commercialization logic, subscription-based economics, and a pre-specified regulatory pathway, including potential relevance to QIDP designation and Priority Review considerations.

"This is not being presented as a recommendation set," said Primarch Michael A. Russell. "It is presented as an implementation framework — a formal structure that can be checked, extended, and applied across domains."

The release is intended to serve as both a public notice and a technical milestone in the development of axiomatic, machine-verifiable invention frameworks.

About Primarch Michael A. Russell
Primarch Michael A. Russell is an independent inventor and researcher focused on axiomatic intelligence, formal systems, and machine-verifiable frameworks for regulated-domain innovation.
Media Contact:
Michael A. Russell
Michael@advanceerivs.com
Advanceer IVS Labs / Universal Standard Axiom Corporation